10-11-2024, 02:27 PM
Sitacure 100, containing Sitagliptin, improves insulin production by inhibiting the enzyme DPP-4 (dipeptidyl peptidase-4), which normally breaks down incretin hormones. Incretins, such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide), play a crucial role in regulating insulin secretion. By blocking DPP-4, Sitacure 100 increases the levels of these incretins, allowing them to enhance insulin release from the pancreas in response to meals. This helps the body better regulate blood sugar levels, particularly after eating, while also reducing the release of glucagon, a hormone that raises blood sugar.